Institutional investors hold a majority ownership of ZTS through the 94.07% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended December 2017, these large investors purchased a net $9.4 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MILESTONE RESOURCES GROUP LTD. Bought 506.6 Thousand shares of Zoetis Inc